Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?

in response to

What's going on with the Phase 2 ZEN-3694 mCRPC trial?

BearDownAZ

posted on Jul 22, 2019 09:19AM

Zenith is a reporting company. It will file updated MD&A's and financials when required to.